TSHA / Taysha Gene Therapies, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Taysha Gene Therapies, Inc.
US ˙ NasdaqGS ˙ US8776191061

Deler fremragende 287,269,885 shares
Insideraktier52.045.466 shares
Insider ejerskab18,12 %
Total Insiders12
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

-2 ( )
9878 out of 10998

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

-0.102% ( )
10209 out of 10864

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Taysha Gene Therapies, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Kamran Alam CHIEF FINANCIAL OFFICER - [O] 1.442.131 1.442.131
Audentes Therapeutics, Inc. 10% Owner - [10%] 7.266.342 7.266.342
Donenberg Phillip B. Director - [D] 219.954 219.954
Alison S Long Director - [D] 105.843 105.843
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Paul B Manning 10% Owner - [10%] 25.601.111 25.601.111
Sukumar Nagendran President and Head of R&D, Director - [D] [O] 1.136.410 1.136.410
Nolan Sean P. Chief Executive Officer, Director - [D] [O] 4.443.802 4.443.802
Suyash Prasad CMO and Head of R&D - [O] 530.589 530.589
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Kathleen Reape 0
Laura Sepp-Lorenzino Director - [D] 105.843 105.843
Session R.A. II 10% Owner - [10%] 9.153.927 9.153.927
Sean Stalfort Director - [D] 2.039.514 2.039.514

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i TSHA / Taysha Gene Therapies, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2025-05-30 Manning Paul B 750.000 2,7500 750.000 2,7500 2.062.500 327 6.7200 2.977.500 144,36
2024-06-27 Manning Paul B 1.333.333 2,2500 1.333.333 2,2500 2.999.999
2023-11-17 Manning Paul B 100.000 1,6300 100.000 1,6300 163.000
2023-08-16 Donenberg Phillip B. 111.111 0,9000 111.111 0,9000 100.000
2023-08-16 Nolan Sean P. 444.444 0,9000 444.444 0,9000 400.000
2023-08-16 Stalfort Sean 388.889 0,9000 388.889 0,9000 350.000
2023-08-16 Stalfort Sean 388.889 0,9000 388.889 0,9000 350.000
2023-08-16 Manning Paul B 16.466.667 0,9000 16.466.667 0,9000 14.820.000
2023-05-16 Nagendran Sukumar 5.000 0,6800 5.000 0,6800 3.400

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TSHA / Taysha Gene Therapies, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i TSHA / Taysha Gene Therapies, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2026-02-04 Alam Kamran 1.655 4,5200 1.655 4,5200 7.481 51 4.0700 -744 -9,95
2026-01-26 Nolan Sean P. 41.312 4,6100 41.312 4,6100 190.448
2026-01-26 Alam Kamran 23.849 4,6100 23.849 4,6100 109.944
2026-01-26 Nagendran Sukumar 26.918 4,6100 26.918 4,6100 124.092
2026-01-23 Nolan Sean P. 136.789 4,7500 136.789 4,7500 649.748
2026-01-23 Alam Kamran 78.968 4,7500 78.968 4,7500 375.098
2026-01-23 Nagendran Sukumar 89.132 4,7500 89.132 4,7500 423.377
2025-12-01 Nagendran Sukumar 260.047 4,5100 260.047 4,5100 1.172.812
2025-11-28 Nagendran Sukumar 110.125 4,7500 110.125 4,7500 523.094

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TSHA / Taysha Gene Therapies, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-04-13 2026-04-10 4 Nagendran Sukumar TSHA Common Stock S - Sale D 4,4600 -200.000 -892 1.136.410
2026-04-13 2026-04-10 4 Nagendran Sukumar TSHA Common Stock M - Exercise D 1,7100 19.021 33 1.336.410
2026-02-06 2026-02-04 4 Alam Kamran TSHA Common Stock S - Sale D 4,5200 -1.655 -7 1.442.131
2026-01-27 2026-01-26 4 Alam Kamran TSHA Common Stock S - Sale D 4,6100 -23.849 -110 1.443.786
2026-01-27 2026-01-23 4 Alam Kamran TSHA Common Stock S - Sale D 4,7500 -78.968 -375 1.467.635
2026-01-27 2026-01-26 4 Nolan Sean P. TSHA Common Stock S - Sale D 4,6100 -41.312 -190 2.908.257
2026-01-27 2026-01-23 4 Nolan Sean P. TSHA Common Stock S - Sale D 4,7500 -136.789 -650 2.949.569
2026-01-27 2026-01-26 4 Nagendran Sukumar TSHA Common Stock S - Sale D 4,6100 -26.918 -124 1.317.389
2026-01-27 2026-01-23 4 Nagendran Sukumar TSHA Common Stock S - Sale D 4,7500 -89.132 -423 1.344.307
2026-01-14 2026-01-12 4 Nagendran Sukumar TSHA Common Stock A - Award D 427.000 1.433.439
2026-01-14 2026-01-12 4 Nagendran Sukumar TSHA Common Stock S - Sale D 4,7100 -200.000 -942 1.006.439
2026-01-14 2026-01-12 4 Nagendran Sukumar TSHA Common Stock M - Exercise D 1,7100 88.676 152 1.206.439
2026-01-14 2026-01-12 4 Nagendran Sukumar TSHA Common Stock M - Exercise D 0,6989 111.324 78 1.117.763
2026-01-14 2026-01-12 4 Nolan Sean P. TSHA Common Stock A - Award D 1.008.000 3.086.358
2026-01-14 2026-01-12 4 Alam Kamran TSHA Common Stock A - Award D 359.000 1.546.603
2025-12-01 2025-12-01 4 Nagendran Sukumar TSHA Common Stock S - Sale D 4,5100 -260.047 -1.173 1.006.439
2025-12-01 2025-12-01 4 Nagendran Sukumar TSHA Common Stock M - Exercise D 1,7100 260.047 445 1.266.486
2025-12-01 2025-11-28 4 Nagendran Sukumar TSHA Common Stock S - Sale D 4,7500 -110.125 -523 1.006.439
2025-12-01 2025-11-28 4 Nagendran Sukumar TSHA Common Stock M - Exercise D 1,7100 39.953 68 1.116.564
2025-12-01 2025-11-28 4 Nagendran Sukumar TSHA Common Stock M - Exercise D 0,6989 70.172 49 1.076.611
2025-09-12 2025-09-10 4 Nagendran Sukumar TSHA Common Stock S - Sale D 3,2300 -200.000 -646 1.006.439
2025-09-12 2025-09-10 4 Nagendran Sukumar TSHA Common Stock M - Exercise D 0,6989 41.150 29 1.206.439
2025-08-22 2025-08-21 4 Alam Kamran TSHA Common Stock S - Sale D 2,8500 -54.491 -155 1.187.603
2025-08-22 2025-08-21 4 Nagendran Sukumar TSHA Common Stock S - Sale D 2,8500 -57.054 -163 1.165.289
2025-06-04 2025-06-02 4 Long Alison S TSHA Common Stock A - Award D 56.623 105.843
2025-06-04 2025-06-02 4 Donenberg Phillip B. TSHA Common Stock A - Award D 56.623 219.954
2025-06-04 2025-06-02 4 Sepp-Lorenzino Laura TSHA Common Stock A - Award D 56.623 105.843
2025-06-04 2025-06-02 4 Stalfort Sean TSHA Common Stock A - Award D 56.623 1.155.224
2025-06-03 2025-05-30 4 Manning Paul B TSHA Common Stock P - Purchase I 2,7500 750.000 2.062 2.841.704
2025-03-13 2025-03-11 4 Alam Kamran TSHA Common Stock F - Taxes D 1,6900 -29.843 -50 1.242.094
2025-01-03 2025-01-02 4 Nolan Sean P. TSHA Common Stock A - Award D 892.500 2.078.358
2025-01-03 2025-01-02 4 Nagendran Sukumar TSHA Common Stock A - Award D 324.500 1.222.343
2025-01-03 2025-01-02 4 Alam Kamran TSHA Common Stock A - Award D 431.000 1.271.937
2024-07-01 2024-06-27 4 Manning Paul B TSHA Common Stock P - Purchase D 2,2500 1.333.333 3.000 1.333.333
2024-05-31 2024-05-29 4 Stalfort Sean TSHA Common Stock A - Award D 49.220 1.098.601
2024-05-31 2024-05-29 4 Sepp-Lorenzino Laura TSHA Common Stock A - Award D 49.220 49.220
2024-05-31 2024-05-29 4 Donenberg Phillip B. TSHA Common Stock A - Award D 49.220 163.331
2024-05-31 2024-05-29 4 Long Alison S TSHA Common Stock A - Award D 49.220 49.220
2024-02-06 2024-02-02 4 Alam Kamran TSHA Common Stock F - Taxes D 1,5100 -1.288 -2 840.937
2024-01-04 2024-01-02 4 Nagendran Sukumar TSHA Common Stock A - Award D 863.617 897.843
2024-01-04 2024-01-02 4 Alam Kamran TSHA Common Stock A - Award D 590.413 842.225
2024-01-04 2024-01-02 4 Nolan Sean P. TSHA Common Stock A - Award D 1.184.688 1.185.858
2023-11-20 2023-11-17 4 Manning Paul B TSHA Common Stock P - Purchase I 1,6300 100.000 163 16.566.667
2023-08-25 2023-08-24 4 Alam Kamran TSHA Common Stock S - Sale D 2,3300 -33.000 -77 258.042
2023-08-16 2023-08-16 4 Manning Paul B TSHA Common Stock P - Purchase I 0,9000 16.466.667 14.820 16.466.667
2023-08-16 2023-08-16 4 Stalfort Sean TSHA Common Stock G - Gift D 50.000 1.049.381
2023-08-16 2023-08-16 4 Stalfort Sean TSHA Common Stock P - Purchase I 0,9000 388.889 350 999.381
2023-08-16 2023-08-16 4 Stalfort Sean TSHA Common Stock P - Purchase D 0,9000 388.889 350 999.381
2023-08-16 2023-08-16 4 Nolan Sean P. TSHA Common Stock P - Purchase I 0,9000 444.444 400 1.535.545
2023-08-16 2023-08-16 4 Donenberg Phillip B. TSHA Common Stock P - Purchase D 0,9000 111.111 100 114.111
2023-07-14 2023-07-13 4 Session R.A. II TSHA Common Stock S - Sale D 0,7000 -5.344 -4 8.871.747
2023-07-14 2023-07-12 4 Session R.A. II TSHA Common Stock S - Sale D 0,7082 -80.528 -57 8.877.091
2023-06-26 2023-06-23 4 Session R.A. II TSHA Common Stock S - Sale D 0,7036 -18.100 -13 8.957.619
2023-06-26 2023-06-22 4 Session R.A. II TSHA Common Stock S - Sale D 0,7027 -10.508 -7 8.975.719
2023-06-26 3 Stalfort Sean TSHA Common Stock I 495.401
2023-06-26 3 Stalfort Sean TSHA Common Stock D 610.492
2023-06-22 2023-06-21 4 Session R.A. II TSHA Common Stock S - Sale D 0,7026 -138.962 -98 8.986.227
2023-06-22 2023-06-20 4 Session R.A. II TSHA Common Stock S - Sale D 0,7110 -295.653 -210 9.125.189
2023-06-02 2023-05-31 4 Alam Kamran TSHA Common Stock A - Award D 6.230 291.042
2023-05-18 2023-05-16 4 Nagendran Sukumar TSHA Common Stock P - Purchase D 0,6800 5.000 3 34.226
2023-03-08 2023-03-06 4 Session R.A. II TSHA Common Stock J - Other D 251.296 9.420.842
2023-02-06 2023-02-02 4 Alam Kamran TSHA Common Stock A - Award D 18.691 284.812
2022-11-02 2022-10-31 4 Manning Paul B TSHA Common Stock P - Purchase D 2,0000 1.500.000 3.000 1.642.202
2022-10-31 3 Astellas Pharma Inc. TSHA Common Stock D 7.266.342
2022-08-24 2022-08-23 4 Alam Kamran TSHA Common Stock S - Sale D 3,4700 -3.325 -12 266.121
2022-08-22 2022-08-22 4 Alam Kamran TSHA Common Stock S - Sale D 3,5000 -9.717 -34 269.446
2022-08-22 2022-08-19 4 Alam Kamran TSHA Common Stock S - Sale D 3,7500 -11.482 -43 279.163
2022-08-22 2022-08-18 4 Alam Kamran TSHA Common Stock S - Sale D 3,8700 -7.476 -29 290.645
2022-07-07 2022-07-06 4 PRASAD SUYASH TSHA Common Stock S - Sale D 3,7900 -8.956 -34 530.589
2022-07-07 2022-07-05 4 PRASAD SUYASH TSHA Common Stock S - Sale D 3,5100 -3.905 -14 539.545
2022-07-01 2022-07-01 4 PRASAD SUYASH TSHA Common Stock S - Sale D 3,5300 -23.923 -84 543.450
2022-07-01 2022-06-30 4 PRASAD SUYASH TSHA Common Stock S - Sale D 3,7200 -13.892 -52 567.373
2022-07-01 2022-06-29 4 PRASAD SUYASH TSHA Common Stock S - Sale D 3,8100 -12.324 -47 581.265
2022-04-08 2022-04-06 4 Alam Kamran TSHA Employee Stock Option (right to buy) A - Award D 6,52 40.000 40.000
2022-04-08 2022-04-06 4 PRASAD SUYASH TSHA Employee Stock Option (right to buy) A - Award D 6,52 40.325 40.325
2022-02-25 2022-02-23 4 PRASAD SUYASH TSHA Employee Stock Option (right to buy) A - Award D 5,96 80.650 80.650
2022-02-25 2022-02-23 4 Alam Kamran TSHA Employee Stock Option (right to buy) A - Award D 5,96 80.000 80.000
2022-02-25 2022-02-23 4 Session R.A. II TSHA Employee Stock Option (right to buy) A - Award D 5,96 217.850 217.850
2022-02-04 2022-02-03 4 Manning Paul B TSHA Common Stock P - Purchase I 7,8400 26.602 209 2.091.704
2022-02-04 2022-02-03 4 Manning Paul B TSHA Common Stock P - Purchase D 7,8400 50.000 392 142.202
2022-02-04 2022-02-02 4 Manning Paul B TSHA Common Stock P - Purchase I 7,7700 22.000 171 22.000
2022-02-04 2022-02-02 4 Manning Paul B TSHA Common Stock P - Purchase I 7,7700 45.000 350 2.065.102
2022-02-04 2022-02-02 4 Manning Paul B TSHA Common Stock P - Purchase D 7,7700 58.000 451 92.202
2022-02-03 2022-02-02 4 Nagendran Sukumar TSHA Common Stock P - Purchase D 8,0100 10.000 80 29.226
2022-02-03 2022-02-02 4 Donenberg Phillip B. TSHA Common Stock P - Purchase D 7,7800 3.000 23 3.000
2021-12-08 2021-11-23 4 Session R.A. II TSHA Common Stock P - Purchase D 12,6500 26.008 329 9.190.920
2021-12-08 2021-11-23 4 Session R.A. II TSHA Common Stock P - Purchase D 12,1200 16.510 200 9.164.912
2021-11-29 2021-11-24 4 Manning Paul B TSHA Common Stock P - Purchase D 13,1900 2.202 29 34.202
2021-11-24 2021-11-23 4 Manning Paul B TSHA Common Stock P - Purchase D 12,5400 20.000 251 32.000
2021-08-20 2021-08-20 4 Alam Kamran TSHA Common Stock S - Sale D 17,1400 -2.094 -36 298.121
2021-08-20 2021-08-20 4 Alam Kamran TSHA Common Stock S - Sale D 16,7000 -9.746 -163 300.215
2021-08-20 2021-08-19 4 Alam Kamran TSHA Common Stock S - Sale D 17,1100 -613 -10 309.961
2021-08-20 2021-08-19 4 Alam Kamran TSHA Common Stock S - Sale D 16,4300 -9.354 -154 310.574
2021-08-20 2021-08-18 4 Alam Kamran TSHA Common Stock S - Sale D 17,3500 -11.193 -194 319.928
2021-07-01 2021-07-01 4 PRASAD SUYASH TSHA Common Stock S - Sale D 21,1200 -19.706 -416 593.589
2021-07-01 2021-06-30 4 PRASAD SUYASH TSHA Common Stock S - Sale D 23,7000 -500 -12 613.295
2021-07-01 2021-06-30 4 PRASAD SUYASH TSHA Common Stock S - Sale D 22,4400 -6.202 -139 613.795
2021-07-01 2021-06-30 4 PRASAD SUYASH TSHA Common Stock S - Sale D 21,4200 -13.374 -286 619.997
2021-07-01 2021-06-29 4 PRASAD SUYASH TSHA Common Stock S - Sale D 25,1900 -300 -8 633.371
2021-07-01 2021-06-29 4 PRASAD SUYASH TSHA Common Stock S - Sale D 24,4600 -3.862 -94 633.671
2021-07-01 2021-06-29 4 PRASAD SUYASH TSHA Common Stock S - Sale D 23,7400 -35.056 -832 637.533
2021-06-21 2021-06-17 4 Donenberg Phillip B. TSHA Stock Option (right to buy) A - Award D 25,04 15.500 15.500
2021-06-21 2021-06-17 4 Nagendran Sukumar TSHA Stock Option (right to buy) A - Award D 25,04 15.500 15.500
2021-06-21 2021-06-17 4 Reape Kathleen TSHA Stock Option (right to buy) A - Award D 25,04 15.500 15.500
2021-06-21 2021-06-17 4 Nolan Sean P. TSHA Stock Option (right to buy) A - Award D 25,04 15.500 15.500
2021-06-21 2021-06-17 4 Sepp-Lorenzino Laura TSHA Stock Option (right to buy) A - Award D 25,04 15.500 15.500
2021-06-21 2021-06-17 4 Manning Paul B TSHA Stock Option (right to buy) A - Award D 25,04 15.500 15.500
2021-05-24 2021-05-20 4 Nolan Sean P. TSHA Common Stock P - Purchase D 22,3500 1.170 26 1.170
2021-05-17 2021-05-14 4 Manning Paul B TSHA Common Stock P - Purchase D 20,9800 12.000 252 12.000
2021-02-16 2020-12-31 5 Manning Paul B TSHA Common Stock G - Gift I -80.000 3.195.205
2021-01-20 2021-01-19 4 Session R.A. II TSHA Stock Option (Right to Buy) A - Award D 31,00 199.700 199.700
2021-01-20 2021-01-19 4 PRASAD SUYASH TSHA Stock Option (Right to Buy) A - Award D 31,00 80.000 80.000
2021-01-20 2021-01-19 4 Alam Kamran TSHA Stock Option (Right to Buy) A - Award D 31,00 70.000 70.000
2020-11-24 2020-11-23 4 Reape Kathleen TSHA Stock Option (right to buy) A - Award D 21,77 31.000 31.000
2020-11-24 2020-11-23 4 Sepp-Lorenzino Laura TSHA Stock Option (right to buy) A - Award D 21,77 31.000 31.000
2020-09-30 2020-09-28 4 PRASAD SUYASH TSHA Series B Preferred Stock C - Conversion D -3.529 0
2020-09-30 2020-09-28 4 PRASAD SUYASH TSHA Common Stock C - Conversion D 3.844 672.589
2020-09-30 2020-09-28 4 Manning Paul B TSHA Series B Preferred Stock C - Conversion I -10.963 0
2020-09-30 2020-09-28 4 Manning Paul B TSHA Series A Preferred Stock C - Conversion I -1.843.193 0
2020-09-30 2020-09-28 4 Manning Paul B TSHA Series A Preferred Stock C - Conversion I -3.006.155 0
2020-09-30 2020-09-28 4 Manning Paul B TSHA Common Stock C - Conversion I 11.944 2.020.102
2020-09-30 2020-09-28 4 Manning Paul B TSHA Common Stock C - Conversion I 2.008.158 2.008.158
2020-09-30 2020-09-28 4 Manning Paul B TSHA Common Stock C - Conversion I 3.275.205 3.275.205
2020-09-30 2020-09-28 4 Nagendran Sukumar TSHA Series B Preferred Stock C - Conversion D -17.647 0
2020-09-30 2020-09-28 4 Nagendran Sukumar TSHA Common Stock C - Conversion D 19.226 19.226
2020-09-30 2020-09-28 4 Nolan Sean P. TSHA Series B Preferred Stock C - Conversion I -1.470 0
2020-09-30 2020-09-28 4 Nolan Sean P. TSHA Series A Preferred Stock C - Conversion I -1.000.000 0
2020-09-30 2020-09-28 4 Nolan Sean P. TSHA Common Stock C - Conversion I 1.601 1.091.101
2020-09-30 2020-09-28 4 Nolan Sean P. TSHA Common Stock C - Conversion I 1.089.500 1.089.500
2020-09-25 2020-09-23 4 Nagendran Sukumar TSHA Stock Option (right to buy) A - Award D 20,00 31.000 31.000
2020-09-25 2020-09-23 4 Nolan Sean P. TSHA Stock Option (right to buy) A - Award D 20,00 31.000 31.000
2020-09-25 2020-09-23 4 PRASAD SUYASH TSHA Common Stock A - Award D 668.745 668.745
2020-09-25 2020-09-23 4 Manning Paul B TSHA Stock Option (right to buy) A - Award D 20,00 31.000 31.000
2020-09-25 2020-09-23 4 Alam Kamran TSHA Common Stock A - Award D 331.121 331.121
2020-09-25 2020-09-23 4 Donenberg Phillip B. TSHA Stock Option (right to buy) A - Award D 20,00 31.000 31.000
2020-09-23 3 Session R.A. II TSHA Common Stock I 141.090
2020-09-23 3 Session R.A. II TSHA Common Stock D 9.148.402
2020-09-23 3 Session R.A. II TSHA Common Stock I 141.090
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista